← Leaderboards
Catherine Driscoll
Georgetown University
$133,116
Attributed
$133,116
Total exposure
6
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$133,116 · 6
By mechanism
M01$133,116 · 6
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Janet E Audrain-McGovern$24,829,618
- Claudine Isaacs$8,250,667
- Hans-Olov Adami$5,245,801
- Marc D Schwartz$16,557,279
- Christopher A Loffredo$8,219,689
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectSickle Cell AnemiaClinical ResearchPatient Oriented ResearchCerebrovascular Imaging /VisualizationStrokeBioimaging /Biomedical ImagingLaboratory MousePathologic ProcessGenetic PolymorphismGenetic SusceptibilityHuman Therapy EvaluationPhenotypeSickle Cell CrisisUltrasound Blood Flow MeasurementBlood TransfusionCardiovascular Disorder PreventionCardiovascular Disorder RiskClinical Trial Phase IiiClinical TrialsDrug Screening /EvaluationGenetically Modified AnimalsGenetic Mapping
Grant awards (6)
PEDIATRIC HYDROXYUREA PHASE III CLINICAL TRIAL: BABY HUG$33,651
M01 · FY2005 · RR
OPTIMIZE PRIMARY STROKE PREVENTION IN CHILDREN W/ SICKLE CELL ANEMIA (STOP II)$21,356
M01 · FY2005 · RR
PLEIOTROPIC &EPISTATIC EFFECTS IN SCA: GENETIC MODIFIERS IN CEREBROVASCULAR DIS$9,707
M01 · FY2005 · RR
Optimizing Primary Stroke Prevention (STOP II)$61,736
M01 · FY2004 · RR
The Genetic Epidemiology of Stroke in Sickle Cell$3,859
M01 · FY2004 · RR
Pleiotropic and Epistatic Effects in Sickle cell Anemia: Genetic Modifiers of Ce$2,807
M01 · FY2004 · RR